By Scientia Professor Carla Treloar

Journal articles

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Hopwood M; Cama E; de Wit J; Treloar C, 2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536

Gray R; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144

Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs Education Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705

Stoové M; Wallace J; Higgs P; Pedrana A; Goutzamanis S; Latham N; Scott N; Treloar C; Crawford S; Doyle J; Hellard M, 2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs Education Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C, 2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016

Bryant J; Rance J; Hull P; Mao L; Treloar C, 2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002

Walker M; Beadman K; Griffin S; Beadman M; Treloar C, 2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, 16, http://dx.doi.org/10.1186/s12954-019-0325-3

Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112

Rhodes T; Lancaster K; Harris M; Treloar C, 2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475

Brener L; Cama E; Broady T; Hopwood M; de Wit J; Treloar C, 2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology Health and Medicine, 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018

Madden A; Hopwood M; Neale J; Treloar C, 2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6

Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J, 2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, 66, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.01.012

Treloar C; Pienaar K; Dilkes-Frayne E; Fraser S, 2019, 'Lives of Substance: a mixed-method evaluation of a public information website on addiction experiences', Drugs Education Prevention and Policy, 26, pp. 140 - 147, http://dx.doi.org/10.1080/09687637.2017.1397602

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, 21, http://dx.doi.org/10.2196/14084

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013

Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J, 2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949

Broady TR; Cama E; Brener L; Hopwood M; de Wit J; Treloar C, 2018, 'Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections', Australian and New Zealand Journal of Public Health, 42, pp. 513 - 515, http://dx.doi.org/10.1111/1753-6405.12809

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987

Levy M; Treloar C, 2018, 'Health protection and Australian prisons, 2018', The Medical Journal of Australia, 209, pp. 460 - 461, http://dx.doi.org/10.5694/mja18.00669

Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?', Plos One, 13, pp. e0207226, http://dx.doi.org/10.1371/journal.pone.0207226

Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia', Harm Reduction Journal, 15, pp. 42, http://dx.doi.org/10.1186/s12954-018-0248-4

Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Building on feminist achievements to enhance choice for women seeking treatment', Addiction, 113, pp. 1001 - 1002, http://dx.doi.org/10.1111/add.14226

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Do women with complex alcohol and other drug use histories want women-only residential treatment?', Addiction, 113, pp. 989 - 997, http://dx.doi.org/10.1111/add.14131

Marshall AD; Treloar C; Dore GJ; Grebely J, 2018, 'A239 QUALITATIVE EVALUATION OF THE DECISIONS AND EXPERIENCES OF PEOPLE WHO INJECT DRUGS WHO RECEIVED A LIVER DISEASE ASSESSMENT AS PART OF A LIVER HEALTH PROMOTION CAMPAIGN: THE LIVERLIFE STUDY', Journal of the Canadian Association of Gastroenterology, 1, pp. 419 - 419, http://dx.doi.org/10.1093/jcag/gwy008.240

Treloar C; Hopwood M; Cama E; Saunders V; Jackson LC; Walker M; Ooi C; Ubrihien A; Ward J, 2018, 'Evaluation of the Deadly Liver Mob program: Insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care', Harm Reduction Journal, 15, pp. 5, http://dx.doi.org/10.1186/s12954-018-0209-y

Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030

Fraser S; Treloar C; Gendera S; Rance J, 2017, '‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention', International Journal of Drug Policy, 50, pp. 19 - 35, http://dx.doi.org/10.1016/j.drugpo.2017.07.001

Marshall AD; Grebely J; Dore GJ; Treloar C, 2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, 47, pp. 153 - 160, http://dx.doi.org/10.1016/j.drugpo.2017.06.001

Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562

Pienaar K; Moore D; Fraser S; Kokanovic R; Treloar C; Dilkes-Frayne E, 2017, 'Diffracting addicting binaries: An analysis of personal accounts of alcohol and other drug ‘addiction’', Health United Kingdom, 21, pp. 519 - 537, http://dx.doi.org/10.1177/1363459316674062

Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C, 2017, 'Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy', International Journal of Drug Policy, 47, pp. 26 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.08.001

Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701

Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ, 2017, 'Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs', International Journal of Drug Policy, 47, pp. 51 - 60, http://dx.doi.org/10.1016/j.drugpo.2017.05.019

Hickman M; Grebely J; Bruneau J; Coffin P; Degenhardt L; Hutchinson S; Larney S; Martin N; Treloar C; Vickerman P, 2017, 'New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs—announcing an Addiction series', Addiction, 112, pp. 1126 - 1127, http://dx.doi.org/10.1111/add.13847

Fraser S; Pienaar K; Dilkes-Frayne E; Moore D; Kokanovic R; Treloar C; Dunlop A, 2017, 'Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis', International Journal of Drug Policy, 44, pp. 192 - 201, http://dx.doi.org/10.1016/j.drugpo.2017.02.005

Wilson H; Brener L; Jackson LC; Saunders V; Johnson P; Treloar C, 2017, 'HCV knowledge among a sample of HCV positive Aboriginal Australians residing in New South Wales', Psychology Health and Medicine, 22, pp. 625 - 632, http://dx.doi.org/10.1080/13548506.2016.1189582

Lancaster K; Treloar C; Ritter A, 2017, '‘Naloxone works’: The politics of knowledge in ‘evidence-based’ drug policy', Health United Kingdom, 21, pp. 278 - 294, http://dx.doi.org/10.1177/1363459316688520

Rhodes T; Rance J; Fraser S; Treloar C, 2017, 'The intimate relationship as a site of social protection: Partnerships between people who inject drugs', Social Science and Medicine, 180, pp. 125 - 134, http://dx.doi.org/10.1016/j.socscimed.2017.03.012

Bryant J; Ellard J; Howard J; Treloar C, 2017, 'Young people at risk of transitioning to injecting: what do they know about where to get sterile needles?', Vulnerable Children and Youth Studies, 12, pp. 138 - 146, http://dx.doi.org/10.1080/17450128.2017.1282071

Rance J; Treloar C; Fraser S; Bryant J; Rhodes T, 2017, '“Don't think I'm going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs', Drug and Alcohol Dependence, 173, pp. 78 - 84, http://dx.doi.org/10.1016/j.drugalcdep.2016.12.020

Lancaster K; Seear K; Treloar C; Ritter A, 2017, 'The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes', Social Science and Medicine, 176, pp. 60 - 68, http://dx.doi.org/10.1016/j.socscimed.2017.01.031

Robotin MC; Porwal M; Hopwood M; Nguyen D; Sze M; Treloar C; George J, 2017, 'Listening to the consumer voice: developing multilingual cancer information resources for people affected by liver cancer', Health Expectations, 20, pp. 171 - 182, http://dx.doi.org/10.1111/hex.12449

Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627

Back to profile page